Long-Term Efficacy of Neoadjuvant Concurrent Chemoradiotherapy for Potentially Resectable Advanced Siewert Type II and III Adenocarcinomas of the Esophagogastric Junction

BACKGROUND: Reports have shown that neoadjuvant concurrent chemoradiotherapy (nCRT) increases the R0 resection rate for patients with Siewert type II or III adenocarcinoma of the gastroesophageal junction (AEG). However, the long-term efficacy of nCRT for AEG patients remains unclear. In this multic...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Yuan, Wang, Jun, Qiao, Xueying, Zhang, Jun, Li, Yong, Fan, Liqiao, Zhang, Zhidong, Zhao, Xuefeng, Tan, Bibo, Wang, Dong, Yang, Peigang, Zhao, Qun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632141/
https://www.ncbi.nlm.nih.gov/pubmed/34858829
http://dx.doi.org/10.3389/fonc.2021.756440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632141/
https://www.ncbi.nlm.nih.gov/pubmed/34858829
http://dx.doi.org/10.3389/fonc.2021.756440

Ejemplares similares